NUDT16P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.560810E-01
Normal-vs-Stage2
4.887600E-01
Normal-vs-Stage3
1.263820E-01
Normal-vs-Stage4
1.569960E-01
Stage1-vs-Stage2
2.780200E-01
Stage1-vs-Stage3
8.317700E-03
Stage1-vs-Stage4
4.972400E-01
Stage2-vs-Stage3
3.895800E-02
Stage2-vs-Stage4
7.813500E-02
Stage3-vs-Stage4
5.393900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.099400E-01
Normal-vs-AfricanAmerican
9.674000E-01
Normal-vs-Asian
4.027000E-01
Caucasian-vs-AfricanAmerican
3.275800E-01
Caucasian-vs-Asian
7.572400E-01
AfricanAmerican-vs-Asian
2.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.234000E-01
Normal-vs-Female
6.193800E-01
Male-vs-Female
1.668600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.069400E-01
Normal-vs-Age(41-60Yrs)
3.767200E-01
Normal-vs-Age(61-80Yrs)
6.166800E-01
Normal-vs-Age(81-100Yrs)
3.393400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.551400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.772400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.905200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.682400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.997400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.058200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.479800E-01
Normal-vs-Daily Drinker
6.051400E-01
Normal-vs-Weekly Drinker
7.111000E-01
Normal-vs-Occasional Drinker
1.757620E-01
Normal-vs-Social Drinker
3.196200E-01
Non Drinker-vs-Daily Drinker
7.499400E-01
Non Drinker-vs-Weekly Drinker
8.476400E-01
Non Drinker-vs-Occasional Drinker
2.120800E-01
Non Drinker-vs-Social Drinker
4.763200E-01
Daily Drinker-vs-Weekly Drinker
9.629200E-01
Daily Drinker-vs-Occasional Drinker
1.120600E-01
Daily Drinker-vs-Social Drinker
3.103600E-01
Weekly Drinker-vs-Occasional Drinker
2.650400E-01
Weekly Drinker-vs-Social Drinker
4.863400E-01
Occasional Drinker-vs-Social Drinker
6.668000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.458500E-02
Normal-vs-Grade 2
1.081890E-02
Normal-vs-Grade 3
1.872280E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.302000E-01
Grade 1-vs-Grade 3
2.657800E-02
Grade 1-vs-Grade 4
2.458500E-02
Grade 2-vs-Grade 3
1.617390E-01
Grade 2-vs-Grade 4
1.081890E-02
Grade 3-vs-Grade 4
1.872280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.119000E-01
Normal-vs-NonDiabetic
4.253200E-01
Diabetic-vs-NonDiabetic
3.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.131000E-01
Normal-vs-NoPancreatitis
5.414000E-01
Pancreatitis-vs-NoPancreatitis
3.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.523600E-01
Normal-vs-N1
5.197800E-01
N0-vs-N1
8.829400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.664500E-02
Normal-vs-TP53-NonMutant
4.460000E-01
TP53-Mutant-vs-TP53-NonMutant
8.170600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
